Cargando…
Bioorthogonal Small Molecule Imaging Agents Allow Single-Cell Imaging of MET
The hepatocyte growth factor receptor (MET) is a receptor tyrosine kinase (RTK) that has emerged as an important cancer target. Consequently, a number of different inhibitors varying in specificity are currently in clinical development. However, to date, it has been difficult to visualize MET expres...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827223/ https://www.ncbi.nlm.nih.gov/pubmed/24265843 http://dx.doi.org/10.1371/journal.pone.0081275 |